ELUVA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 9,943 | 8,816 | 9,918 | 20,069 | 44,298 | 61,639 | 13,101 | 7,617 |
| Profit before tax | -27,006 | 33,976 | -7,043 | -6,338 | 11,526 | 13,867 | -9,847 | -2,205 |
| Net profit | -27,006 | 33,976 | -7,043 | -6,338 | 11,526 | 13,867 | -9,847 | -2,205 |
| Equity | -83,612 | -49,636 | -56,679 | -63,017 | -51,491 | -37,624 | -47,471 | -49,676 |
| Liabilities | 129,290 | 92,685 | 97,535 | 107,008 | 119,869 | 92,168 | 84,291 | 74,652 |
| Non-current assets | 28,203 | 26,720 | 25,237 | 23,754 | 22,293 | 20,845 | 19,396 | 17,948 |
| Current assets | 17,475 | 16,329 | 15,619 | 20,237 | 46,085 | 33,699 | 17,424 | 7,028 |
| Total assets | 45,678 | 43,049 | 40,856 | 43,991 | 68,378 | 54,544 | 36,820 | 24,976 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 13,849 | 5,275 | 2,337 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +26.4% | -11.3% | +12.5% | +102.3% | +120.7% | +39.1% | -78.7% | -41.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -59.1% | 78.9% | -17.2% | -14.4% | 16.9% | 25.4% | -26.7% | -8.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -271.6% | 385.4% | -71.0% | -31.6% | 26.0% | 22.5% | -75.2% | -28.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -271.6% | 385.4% | -71.0% | -31.6% | 26.0% | 22.5% | -75.2% | -28.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 4,972 | 4,408 | 4,959 | 10,035 | 22,149 | 30,820 | 6,551 | 3,809 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ELUVA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-16 | 2026-06-17 | 308.65 |
| 2026-01-16 | 2026-01-19 | 280.73 |
| 2025-05-16 | 2025-05-18 | 280.74 |
| 2025-02-18 | 2025-02-18 | 280.77 |
| 2024-11-18 | 2024-11-18 | 248.24 |
| 2024-07-16 | 2024-07-18 | 248.17 |
| 2024-03-18 | 2024-03-18 | 248.17 |
| 2023-08-17 | 2023-08-17 | 227.79 |
ELUVA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ELUVA, UAB (code 123038064) is a private limited liability company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated EUR 7.6K in revenue, down 41.9% year on year and 87.6% over two years, showing a continued contraction in activity. Net loss for 2025 was EUR 2.2K, an improvement from the EUR 9.8K loss in 2024, while 2023 still showed a net profit of EUR 13.9K on revenue of EUR 61.6K. The profit margin weakened from 22.5% in 2023 to -75.2% in 2024 and -28.9% in 2025, reflecting the decline in turnover and weaker operating results. At the end of 2025, total assets were EUR 25.0K, equity stood at -EUR 49.7K, and liabilities were EUR 74.7K. Assets declined from EUR 54.5K in 2023 and EUR 36.8K in 2024, while liabilities also fell from EUR 92.2K in 2023. Revenue per employee in 2025 was EUR 3.8K, and profit per employee was -EUR 1.1K. Profitability and leverage ratios should be interpreted cautiously because equity remained negative throughout the period.